Medicianz Healthcare Pty Ltd — Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL

PRA number

2022/19366

Published date

Product description

Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL

Batch numbers: 12636, 12639, 12868, 13057, 13061, 13260, 13510, 13626, 13969, 13971, 15338, 15344, 16265, 16375 and 16470

Supplied via Special Access Scheme (SAS)

What are the defects?

The Lidocaine Hydrochloride topical solution can become stronger than intended.

What are the hazards?

An increased dose of Lidocaine could lead to the development of local anaesthetic toxicity and this may result in serious adverse health effects.

What should consumers do?

Consumers should immediately stop using the product and return it to the place of purchase or contact Medicianz Healthcare to arrange for credit note.

Any consumers concerned about their health should seek medical advice.

For further information, call Medicianz Healthcare on 1300 788 261.

Traders who sold this product

Hospitals in NSW, QLD, VIC and WA

Where the product was sold

Nationally

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category